anmelden
Stoxx Europe 50
5.068,47
PKT
+21,19
PKT
+0,42
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu Stoxx Europe 50-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 31.01.25 | Novartis Buy | UBS AG | |
| 31.01.25 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 31.01.25 | Roche Neutral | UBS AG | |
| 31.01.25 | LOréal Neutral | UBS AG | |
| 31.01.25 | Sanofi Buy | UBS AG | |
| 31.01.25 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 31.01.25 | BBVA Buy | Deutsche Bank AG | |
| 31.01.25 | Intesa Sanpaolo Overweight | JP Morgan Chase & Co. | |
| 31.01.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 31.01.25 | Novartis Outperform | Bernstein Research | |
| 31.01.25 | Prosus Overweight | JP Morgan Chase & Co. | |
| 31.01.25 | Rheinmetall Buy | Deutsche Bank AG | |
| 31.01.25 | Sanofi Hold | Deutsche Bank AG | |
| 31.01.25 | Novartis Hold | Jefferies & Company Inc. | |
| 31.01.25 | SAP Buy | Goldman Sachs Group Inc. | |
| 31.01.25 | ASML NV Outperform | Bernstein Research | |
| 31.01.25 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 30.01.25 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 30.01.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 30.01.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 30.01.25 | ASML NV Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.01.25 | ASML NV Buy | Deutsche Bank AG | |
| 30.01.25 | Sanofi Outperform | Bernstein Research | |
| 30.01.25 | Roche Outperform | Bernstein Research | |
| 30.01.25 | ABB (Asea Brown Boveri) Underperform | Bernstein Research | |
| 30.01.25 | LVMH Moet Hennessy Louis Vuitton Outperform | Bernstein Research | |
| 30.01.25 | Schneider Electric Outperform | Bernstein Research | |
| 30.01.25 | ASML NV Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | Deutsche Telekom Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | EssilorLuxottica Neutral | UBS AG | |
| 30.01.25 | GSK Neutral | UBS AG | |
| 30.01.25 | SAP Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | AstraZeneca Neutral | UBS AG | |
| 30.01.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 30.01.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 30.01.25 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 30.01.25 | Roche Neutral | UBS AG | |
| 30.01.25 | Sanofi Buy | UBS AG | |
| 30.01.25 | Roche Sell | Goldman Sachs Group Inc. |